Quick Takeaways
- Rubric Capital Management LP filed SCHEDULE 13D/A for HERON THERAPEUTICS, INC. /DE/ Common Stock, par value $0.01 per share (HRTX).
- Disclosed ownership: 18%.
- Date of event: 08 Aug 2025.
Rubric Capital Management LP - 08 Aug 2025 SCHEDULE 13D/A Report for HERON THERAPEUTICS, INC. /DE/ Common Stock, par value $0.01 per share (HRTX)
- Filing Manager
- Rubric Capital Management LP
- Reporting Manager
- Rubric Capital Management LP
- Symbol
- HRTX
- Shares outstanding
- 166,289,874 shares
- Disclosed Ownership
- 29,100,728 shares
- Ownership
- 18%
- Form type
- SCHEDULE 13D/A
- Filing time
- 12 Aug 2025, 18:00:55 UTC
- Date of event
- 08 Aug 2025
- Next filing
- 17 Oct 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Rubric Capital Management LP disclosed 18% ownership in HERON THERAPEUTICS, INC. /DE/ Common Stock, par value $0.01 per share (HRTX) on 08 Aug 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 12 Aug 2025, 18:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Rubric Capital Management LP | 18% | 29,100,728 | 0 | 29,100,728 | /s/ David Rosen | By: Rubric Capital Management GP LLC, General Partner, By: David Rosen, Managing Member | 0001687509 |
| David Rosen | 18% | 29,100,728 | 0 | 29,100,728 | /s/ David Rosen | David Rosen, Individually | 0001898677 |